case study: mutation-negative patient with lung adenocarcinoma
Published 10 years ago • 2.3K plays • Length 8:36Download video MP4
Download video MP3
Similar videos
-
4:59
case study: treating kras-mutant adenocarcinoma
-
9:14
case study: second-line treatment of adenocarcinoma
-
2:49
case 2: stage iv pd-l1–negative, kras-mutant lung adenocarcinoma
-
7:23
chemotherapy for advanced lung cancer
-
9:23
mutation testing for all patients with nsclc
-
6:13
case study: treating an elderly patient with squamous non-small cell lung cancer
-
5:24
less common mutations in lung adenocarcinoma
-
1:59
dr. tolba on the use of afatinib in nrg1-mutated lung adenocarcinoma
-
6:04
case study: progression on alk inhibitors in nsclc
-
5:58
common mutations in lung cancer
-
6:57
egfr exon 20 mutations in non–small cell lung cancer
-
4:05
first-line chemotherapy options in lung adenocarcinoma
-
4:26
case study: maintenance therapy in squamous non-small cell lung cancer
-
6:30
testing for kras mutations in nsclc
-
6:56
first-line therapy in the patient with egfr-mutant lung cancer
-
6:45
lung adenocarcinoma: patient selection with ramucirumab vs nintedanib
-
1:06
dr. goldman on targeted therapy options for egfr-, alk-, and ros1-mutated nsclc
-
8:03
driver mutations trump pd-l1 expression in lung adenocarcinoma
-
4:42
practical considerations with nintedanib in lung adenocarcinoma